Steven P Bitler
CIK 1192866 · Vice President, Technology · last filed 2018-05-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LNDC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Vice President, Technology | 74,666 | $8.76 | $654.1K | -$874.6K | 24 | 2018-05-25 |
Recent Filings · Page 2 of 3
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-10-09 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | — | -$25.6K | EDGAR |
| 2012-10-03 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | −10,000 | -$88.6K | EDGAR |
| 2012-05-23 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | +2,956 | $0 | EDGAR |
| 2010-10-13 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Sell (S) | −10,000 | -$62.9K | EDGAR |
| 2010-05-27 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | — | $0 | EDGAR |
| 2010-04-01 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +15,000 | $28.4K | EDGAR |
| 2009-06-16 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Exer (M) | +1,935 | $0 | EDGAR |
| 2009-05-26 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-20 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Sell (S) | −5,984 | -$37.8K | EDGAR |
| 2009-02-09 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +10,000 | $49.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.